Search research articles
Contact Us
Filters
Showing results (201-210 of 499) with videos related to
Page
of 50
Sort By:
Translational Oncology
|
April 17, 2016
A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma
Jeroen Dekervel, Dusan Popovic, Hannah van Malenstein, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 11, 2020
Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of <sup>177</sup>Lu-DOTATATE PRRT
Eva Medaer, Chris Verslype, Eric Van Cutsem, et al.
Clinical Colorectal Cancer
|
July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database
Winson Y Cheung, Qian Shi, Michael O'Connell, et al.
Journal of the National Cancer Institute
|
October 30, 2012
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
Arnaud D Roth, Mauro Delorenzi, Sabine Tejpar, et al.
Translational Oncology
|
March 8, 2020
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
Ashenafi Bulle, Jeroen Dekervel, Lise Deschuttere, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 2, 2019
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer
Manish A Shah, Yoon-Koo Kang, Peter C Thuss-Patience, et al.
Journal of Cancer Research and Clinical Oncology
|
April 13, 2018
MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach
Hans-Joachim Schmoll, Dirk Arnold, Aimery de Gramont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group
Eric Van Cutsem, Vladimir M Moiseyenko, Sergei Tjulandin, et al.
Targeted Oncology
|
February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors
James J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2025
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial
Julien Taieb, Dominik P Modest, Marwan Fakih, et al.
Page
of 50
Search research articles
Search
Showing results (201-210 of 499) with videos related to
Sort By:
Page
of 50
Translational Oncology
|
April 17, 2016
A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma
Jeroen Dekervel, Dusan Popovic, Hannah van Malenstein, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 11, 2020
Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of <sup>177</sup>Lu-DOTATATE PRRT
Eva Medaer, Chris Verslype, Eric Van Cutsem, et al.
Clinical Colorectal Cancer
|
July 2, 2013
The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database
Winson Y Cheung, Qian Shi, Michael O'Connell, et al.
Journal of the National Cancer Institute
|
October 30, 2012
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
Arnaud D Roth, Mauro Delorenzi, Sabine Tejpar, et al.
Translational Oncology
|
March 8, 2020
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
Ashenafi Bulle, Jeroen Dekervel, Lise Deschuttere, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 2, 2019
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer
Manish A Shah, Yoon-Koo Kang, Peter C Thuss-Patience, et al.
Journal of Cancer Research and Clinical Oncology
|
April 13, 2018
MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach
Hans-Joachim Schmoll, Dirk Arnold, Aimery de Gramont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group
Eric Van Cutsem, Vladimir M Moiseyenko, Sergei Tjulandin, et al.
Targeted Oncology
|
February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors
James J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2025
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial
Julien Taieb, Dominik P Modest, Marwan Fakih, et al.
Page
of 50